Retraction Note: A prospective, double-blind, randomized, placebo-controlled clinical trial of bromocriptin in clomiphene-resistant patients with polycystic ovary syndrome and normal prolactin level
Arch Gynecol Obstet
.
2024 Feb;309(2):729.
doi: 10.1007/s00404-023-07330-z.
Authors
Mohammad Ebrahim Parsanezhad
1
2
,
Saeed Alborzi
3
,
Bahia Namavar Jahromi
3
Affiliations
1
Department of Obstetrics and Gynecology, Medical School, Shiraz University of Medical Sciences, Shiraz, Iran.
[email protected]
.
2
, Parsanezhad Jenaer Str 41, 28215, Bremen, Germany.
[email protected]
.
3
Department of Obstetrics and Gynecology, Medical School, Shiraz University of Medical Sciences, Shiraz, Iran.
PMID:
38142249
DOI:
10.1007/s00404-023-07330-z
No abstract available
Publication types
Retraction of Publication